Johnson & Johnson (NYSE:JNJ) Announces Quarterly Earnings Results

Johnson & Johnson (NYSE:JNJ) announced its earnings results on Tuesday. The company reported $2.48 EPS for the quarter, beating analysts’ consensus estimates of $2.29 by $0.19, MarketWatch Earnings reports. The company had revenue of $23.31 billion during the quarter, compared to the consensus estimate of $22.54 billion. Johnson & Johnson had a return on equity of 34.62% and a net margin of 17.95%. The firm’s revenue for the quarter was up 27.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.67 earnings per share.

JNJ traded up $0.69 during trading on Thursday, reaching $170.18. The stock had a trading volume of 113,242 shares, compared to its average volume of 6,223,537. The firm’s 50 day simple moving average is $167.25. The company has a quick ratio of 1.04, a current ratio of 1.28 and a debt-to-equity ratio of 0.46. The company has a market capitalization of $448.15 billion, a P/E ratio of 30.07, a price-to-earnings-growth ratio of 2.71 and a beta of 0.71. Johnson & Johnson has a one year low of $133.65 and a one year high of $173.65.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 7th. Shareholders of record on Tuesday, August 24th will be issued a $1.06 dividend. The ex-dividend date of this dividend is Monday, August 23rd. This represents a $4.24 dividend on an annualized basis and a yield of 2.49%. Johnson & Johnson’s dividend payout ratio (DPR) is 52.80%.

A number of equities analysts recently commented on the company. Credit Suisse Group set a $193.00 target price on Johnson & Johnson and gave the company a “buy” rating in a report on Monday, June 7th. Morgan Stanley assumed coverage on Johnson & Johnson in a report on Friday, May 28th. They set an “overweight” rating and a $187.00 target price for the company. Two research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $190.38.

A hedge fund recently bought a new stake in Johnson & Johnson stock. OLD Mission Capital LLC bought a new position in Johnson & Johnson (NYSE:JNJ) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 2,432 shares of the company’s stock, valued at approximately $362,000. Institutional investors own 66.60% of the company’s stock.

About Johnson & Johnson

Johnson & Johnson researches and develops, manufactures, and sells a range of products in the health care field worldwide. It operates through three segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR.

Featured Article: How to calculate compound interest

Earnings History for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with's FREE daily email newsletter.